The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
INmune Bio, Inc(NASDAQ:INMB) 
INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on reprogramming the patient's innate immune system to treat cancer Alzheimer's disease, and non-alcoholic steatohepatitis. The company intends to develop and commercialize product candidates to treat hematologic malignancies, solid t...
INmune Bio Days Receivable Outstanding ttm (DSO)
INmune Bio Op Cashflow Per Share ttm
INmune Bio Free Cashflow Per Share ttm
INmune Bio Cash Per Share ttm
INmune Bio P/S ratio ttm
INmune Bio (GAAP) P/E ratio ttm
INmune Bio P/B ratio ttm
No extra charts and metrics for this ticker.